Regencell Bioscience Holdings Limited (RGC)

NASDAQ: RGC · IEX Real-Time Price · USD

6.49

+0.62 (10.56%)

At close: May 2, 2024, 4:00 PM

5.33

-1.16 (-17.87%)

After-hours: May 3, 2024, 4:21 PM EDT

RGC Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	2023	2022	2021	2020	2019
Net Income	-5.87	-7.45	-1.35	-0.81	-0.39
Depreciation & Amortization	0.77	0.6	0.03	0.01	0
Share-Based Compensation	0.92	2.76	0	0	0
Other Operating Activities	-0.78	-1.18	0.55	0.08	-
Operating Cash Flow	-4.96	-5.27	-0.77	-0.73	-0.39
Capital Expenditures	-0.03	-0.78	0	-0.12	0
Change in Investments	0.09	-10	0	0	0
Investing Cash Flow	0.06	-10.78	0	-0.12	0
Share Issuance / Repurchase	0	22.67	0	0	0
Debt Issued / Paid	0	-0.43	0.61	0.99	0.48
Other Financing Activities	0.13	0.16	-0.17	-	-
Financing Cash Flow	0.13	22.41	0.44	0.99	0.48
Exchange Rate Effect	-0.08	0	0	0	0
Net Cash Flow	-4.85	6.36	-0.33	0.14	0.09
Free Cash Flow	-4.99	-6.05	-0.77	-0.84	-0.39
Free Cash Flow Per Share	-0.38	-0.47	-0.08	-0.08	-0.04

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).